Il y a eu 50 transactions d'initiés récentes enregistrées pour Cerevel Therapeutics Holdings, Inc. (CERE), dont 20 achats et 29 ventes. Le total des achats d'initiés s'élève à RSU Award et le total des ventes d'initiés à $4.2B.
Les initiés notables ayant une activité récente comprennent Pfizer Inc, Bain Capital Investors Llc, Patrick Deval L. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — CERE
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2024-08-01 |
Pfizer Inc |
Other: Former 10% Owner |
OPA (Vente) |
27,349,211 |
$45.00 |
$1.23B |
- |
| 2024-08-01 |
Bain Capital Investors Llc |
10 Percent Owner |
Restitution d'Actions |
65,679,781 |
$45.00 |
$2.96B |
- |
| 2024-08-01 |
Patrick Deval L |
Director |
Restitution d'Actions |
49,794 |
- |
- |
- |
| 2024-08-01 |
Riedel Norbert G |
Director |
Restitution d'Actions |
95,242 |
- |
- |
- |
| 2024-08-01 |
Coles N Anthony |
Director |
Restitution d'Actions |
4,809,418 |
- |
- |
- |
| 2024-08-01 |
Dekkers Marijn E |
Director |
Restitution d'Actions |
95,242 |
- |
- |
- |
| 2024-08-01 |
Sulzberger Gabrielle |
Director |
Restitution d'Actions |
95,242 |
- |
- |
- |
| 2024-08-01 |
Renaud Ronald C Jr |
President & CEO |
Restitution d'Actions |
320,742 |
- |
- |
- |
| 2024-08-01 |
Giordano Douglas E. |
Director |
Restitution d'Actions |
95,242 |
- |
- |
- |
| 2024-08-01 |
Gordon Christopher R |
10 Percent Owner |
Restitution d'Actions |
80,189 |
- |
- |
- |
| 2024-08-01 |
Mckernan Ruth |
Director |
Restitution d'Actions |
92,986 |
- |
- |
- |
| 2024-08-01 |
Dipietro Kenneth |
Chief Human Resources Officer |
Restitution d'Actions |
63,905 |
- |
- |
- |
| 2024-08-01 |
Koppel Adam |
10 Percent Owner |
Restitution d'Actions |
80,189 |
- |
- |
- |
| 2024-08-01 |
Burgess Paul D. |
See Remarks |
Restitution d'Actions |
81,065 |
- |
- |
- |
| 2024-08-01 |
Akamine Scott |
Chief Legal Officer |
Restitution d'Actions |
59,171 |
- |
- |
- |
| 2024-08-01 |
Altschuller Susan |
Chief Financial Officer |
Restitution d'Actions |
81,065 |
- |
- |
- |
| 2024-08-01 |
Sanchez Ramiro |
Chief Medical Officer |
Restitution d'Actions |
87,573 |
- |
- |
- |
| 2024-08-01 |
Renger John |
Chief Scientific Officer |
Restitution d'Actions |
87,573 |
- |
- |
- |
| 2024-08-01 |
Bodenrader Mark |
See Remarks |
Restitution d'Actions |
24,852 |
- |
- |
- |
| 2024-08-01 |
Tregoning Kathleen |
See Remarks |
Restitution d'Actions |
59,171 |
- |
- |
- |
| 2024-07-01 |
Coles N Anthony |
Director |
Vente Informative |
25,000 |
$41.18 |
$1.03M |
25,928 |
| 2024-06-05 |
Patrick Deval L |
Director |
Attribution de RSU |
10,461 |
- |
- |
13,743 |
| 2024-06-05 |
Riedel Norbert G |
Director |
Attribution de RSU |
10,461 |
- |
- |
56,553 |
| 2024-06-05 |
Coles N Anthony |
Director |
Attribution de RSU |
10,290 |
- |
- |
25,928 |
| 2024-06-05 |
Dekkers Marijn E |
Director |
Attribution de RSU |
10,461 |
- |
- |
42,283 |
| 2024-06-05 |
Sulzberger Gabrielle |
Director |
Attribution de RSU |
10,461 |
- |
- |
58,876 |
| 2024-06-05 |
Giordano Douglas E. |
Director |
Attribution de RSU |
10,461 |
- |
- |
13,743 |
| 2024-06-05 |
Gordon Christopher R |
10 Percent Owner |
Attribution de RSU |
10,461 |
- |
- |
13,743 |
| 2024-06-05 |
Mckernan Ruth |
Director |
Attribution de RSU |
10,461 |
- |
- |
13,743 |
| 2024-06-05 |
Koppel Adam |
10 Percent Owner |
Attribution de RSU |
10,461 |
- |
- |
13,743 |
| 2024-06-03 |
Coles N Anthony |
Director |
Vente Informative |
50,000 |
$40.61 |
$2.03M |
15,638 |
| 2024-05-10 |
Coles N Anthony |
Director |
Vente Informative |
50,000 |
$42.10 |
$2.11M |
15,638 |
| 2024-04-01 |
Coles N Anthony |
Director |
Vente Informative |
50,000 |
$42.33 |
$2.12M |
15,638 |
| 2024-03-04 |
Coles N Anthony |
Director |
Vente Informative |
50,000 |
$41.01 |
$2.05M |
15,638 |
| 2024-02-29 |
Coles N Anthony |
Director |
Vente Informative |
50,000 |
$41.16 |
$2.06M |
15,638 |
| 2024-02-20 |
Perceptive Advisors Llc |
Director |
Don (Donné) |
170,317 |
- |
- |
- |
| 2024-02-07 |
Coles N Anthony |
Director |
Vente Informative |
2,506 |
$41.54 |
$104.11K |
15,638 |
| 2024-02-07 |
Renger John |
Chief Scientific Officer |
Vente Informative |
2,161 |
$41.54 |
$89.78K |
6,370 |
| 2024-02-06 |
Coles N Anthony |
Director |
Exercice d'Options |
15,440 |
- |
- |
18,144 |
| 2024-02-06 |
Renger John |
Chief Scientific Officer |
Exercice d'Options |
5,020 |
- |
- |
8,531 |
| 2024-01-19 |
Renaud Ronald C Jr |
President & CEO |
Attribution de RSU |
284,023 |
- |
- |
284,023 |
| 2024-01-19 |
Dipietro Kenneth |
Chief Human Resources Officer |
Attribution de RSU |
63,905 |
- |
- |
63,905 |
| 2024-01-19 |
Burgess Paul D. |
See Remarks |
Attribution de RSU |
81,065 |
- |
- |
81,065 |
| 2024-01-19 |
Akamine Scott |
Chief Legal Officer |
Attribution de RSU |
59,171 |
- |
- |
59,171 |
| 2024-01-19 |
Altschuller Susan |
Chief Financial Officer |
Attribution de RSU |
81,065 |
- |
- |
81,065 |
| 2024-01-19 |
Sanchez Ramiro |
Chief Medical Officer |
Attribution de RSU |
87,573 |
- |
- |
87,573 |
| 2024-01-19 |
Renger John |
Chief Scientific Officer |
Attribution de RSU |
87,573 |
- |
- |
87,573 |
| 2024-01-19 |
Bodenrader Mark |
See Remarks |
Attribution de RSU |
24,852 |
- |
- |
24,852 |
| 2024-01-19 |
Tregoning Kathleen |
See Remarks |
Attribution de RSU |
59,171 |
- |
- |
59,171 |
| 2024-01-02 |
Coles N Anthony |
Director |
Vente Informative |
50,000 |
$42.24 |
$2.11M |
2,704 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
